# Broadway Financial Corp \\de\\: overview BYFC · Nasdaq · CIK 1001171 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/byfc.md) · [Financials](/companies/byfc/financials.md) · [Filings](/companies/byfc/filings.md) · [Insiders](/companies/byfc/insiders.md) Latest reported revenue: [$44.0k](/filings/0001140361-26-032726.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001140361-26-032726). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [36.0](/filings/0001140361-26-005265.md) | [41.0 d](/filings/0001140361-26-012311.md) | [43.0](/filings/0001140361-26-021646.md) | [41.0](/filings/0001140361-26-032726.md) | [47.0](/filings/0001140361-26-005265.md) | [53.0 d](/filings/0001140361-26-012311.md) | [44.0](/filings/0001140361-26-021646.md) | [44.0](/filings/0001140361-26-032726.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [1433.3%](/filings/0001140361-26-005265.md) | [3197.6% d](/filings/0001140361-25-046590.md) | [(6253.5%)](/filings/0001140361-26-021646.md) | [1834.1%](/filings/0001140361-26-032726.md) | [(50814.9%)](/filings/0001140361-26-005265.md) | [1934.0% d](/filings/0001140361-26-012311.md) | [2634.1%](/filings/0001140361-26-021646.md) | [2200.0%](/filings/0001140361-26-032726.md) | | Diluted EPS | $ per share | [(0.03)](/filings/0001140361-26-005265.md) | [0.06](/filings/0001140361-25-046590.md) | [(0.39)](/filings/0001140361-26-021646.md) | [0.00](/filings/0001140361-26-032726.md) | [(2.86)](/filings/0001140361-26-005265.md) | not reported | [0.05](/filings/0001140361-26-021646.md) | [0.02](/filings/0001140361-26-032726.md) | | Free cash flow | $k | [6,087 d](/filings/0001140361-26-005265.md) | [(2,851) d](/filings/0001140361-26-012311.md) | [(4,363)](/filings/0001140361-26-021646.md) | [2,998 d](/filings/0001140361-26-032726.md) | [3,718 d](/filings/0001140361-26-005265.md) | [(2,366) d](/filings/0001140361-26-012311.md) | [1,094](/filings/0001140361-26-021646.md) | [3,738 d](/filings/0001140361-26-032726.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [249](/filings/0001140361-23-017732.md) | [145](/filings/0001140361-24-026827.md) | [179](/filings/0001140361-25-046590.md) | [155](/filings/0001140361-26-012311.md) | [184](/filings/0001140361-26-012311.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [(1626.5%)](/filings/0001140361-23-017732.md) | [3886.9%](/filings/0001140361-24-026827.md) | [2417.3%](/filings/0001140361-25-046590.md) | [1244.5%](/filings/0001140361-26-012311.md) | [(13475.5%)](/filings/0001140361-26-012311.md) | | Diluted EPS | $ per share | [(0.07)](/filings/0001140361-23-017732.md) | [0.62](/filings/0001140361-24-026827.md) | [0.49](/filings/0001140361-25-046590.md) | [0.04](/filings/0001140361-26-012311.md) | [(3.23)](/filings/0001140361-26-012311.md) | | Free cash flow | $k | [(514)](/filings/0001140361-23-017732.md) | [6,001](/filings/0001140361-24-026827.md) | [7,386](/filings/0001140361-25-046590.md) | [1,255](/filings/0001140361-26-012311.md) | [(13.0)](/filings/0001140361-26-012311.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/byfc/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.0m | 313,765 | | Reduced −191 | | [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $2.6m | 266,492 | | Unchanged | | [GRACE & WHITE INC /NY](/funds/903064.md) | 2026-06-30 | $1.7m | 175,965 | | Reduced −1,120 | | [US BANCORP \\DE\\](/funds/36104.md) | 2026-06-30 | $680.6k | 70,458 | | Reduced −1,120 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $676.6k | 70,024 | | Added +1,041 | | [WITTENBERG INVESTMENT MANAGEMENT, INC.](/funds/1697790.md) | 2026-06-30 | $542.5k | 56,156 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $294.4k | 30,480 | | Added +191 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $154.0k | 15,944 | | Added +4,042 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $139.8k | 14,470 | | Added +200 | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $115.7k | 11,979 | | Reduced −3,254 | ## Recent filings [All 777 filings](/companies/byfc/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-02 | 20:29 ET | [8-K](/filings/0001140361-26-038424.md) | 5.02 Departure or appointment of officers or directors | 0001140361-26-038424 | | 2026-08-13 | 16:15 ET | [10-Q](/filings/0001140361-26-032726.md) | Quarterly report, period 2026-06-30 | 0001140361-26-032726 | | 2026-07-28 | 20:20 ET | [8-K](/filings/0001140361-26-029886.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-029886 | | 2026-06-23 | 19:58 ET | [8-K](/filings/0001140361-26-026086.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-026086 | | 2026-06-18 | 20:45 ET | [8-K](/filings/0001140361-26-025775.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-025775 | | 2026-06-03 | 20:15 ET | [8-K](/filings/0001140361-26-023884.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-023884 | | 2026-05-15 | 20:01 ET | [10-Q](/filings/0001140361-26-021646.md) | Quarterly report, period 2026-03-31 | 0001140361-26-021646 | | 2026-05-15 | 19:37 ET | [8-K/A](/filings/0001140361-26-021631.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-021631 | | 2026-04-30 | 20:37 ET | [DEF 14A](/filings/0001140361-26-018278.md) | Proxy statement, period 2026-06-17 | 0001140361-26-018278 | | 2026-04-28 | 20:20 ET | [8-K](/filings/0001140361-26-017451.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-017451 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001140361-26-012311.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/7e6f6807-6405-4377-9fe6-1ef3a8323988) ## About the filer - CIK: 1001171 - Tickers: BYFC - Exchange: Nasdaq - SIC code: 6035 Savings Institution, Federally Chartered - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.